Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedJun 11, 2026
DataAggregated Company Financials
Companies9
  • 7D6.7%
  • 3M8.7%
  • 1Y-17.1%
  • YTDn/a

In the last week, the Clinical Research and Equipment industry is up 6.7%, with AddLife up 11%. Meanwhile, Magle Chemoswed Holding actually underperformed within the industry, shrinking 66% in the last week. In the past year, the industry is down 17%. Earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 11 Jun 2026SEK 29.8bSEK 14.6b-SEK 871,304,353.0033.9x-34.2x2x
Sat, 09 May 2026SEK 28.5bSEK 14.6b-SEK 853,896,077.0033.9x-33.3x1.9x
Mon, 06 Apr 2026SEK 27.4bSEK 14.6b-SEK 971,664,077.0032.5x-28.1x1.9x
Wed, 04 Mar 2026SEK 27.8bSEK 14.6b-SEK 838,240,147.0033.1x-33.2x1.9x
Fri, 30 Jan 2026SEK 27.8bSEK 14.9b-SEK 744,515,427.0042.9x-37.3x1.9x
Sun, 28 Dec 2025SEK 31.5bSEK 14.9b-SEK 744,515,427.0050.2x-42.4x2.1x
Tue, 25 Nov 2025SEK 33.8bSEK 14.9b-SEK 744,515,427.0056.5x-45.5x2.3x
Thu, 23 Oct 2025SEK 35.0bSEK 14.7bSEK 61.3m56.5x572.1x2.4x
Sat, 20 Sep 2025SEK 36.3bSEK 14.7bSEK 61.3m56.4x592.6x2.5x
Mon, 18 Aug 2025SEK 34.9bSEK 14.8bSEK 161.3m58.6x216.2x2.4x
Wed, 16 Jul 2025SEK 46.3bSEK 16.6bSEK 416.3m67.4x111.2x2.8x
Fri, 13 Jun 2025SEK 47.0bSEK 16.6bSEK 404.2m69x116.4x2.8x
Sun, 11 May 2025SEK 46.1bSEK 16.6bSEK 420.1m44.5x109.7x2.8x
Tue, 08 Apr 2025SEK 33.8bSEK 16.6bSEK 609.4m37.9x55.5x2x
Thu, 06 Mar 2025SEK 39.4bSEK 16.6bSEK 615.4m40.2x64x2.4x
Sat, 01 Feb 2025SEK 41.3bSEK 16.7b-SEK 1,152,911,426.0044.2x-35.8x2.5x
Mon, 30 Dec 2024SEK 44.2bSEK 16.7b-SEK 1,152,911,426.0050.9x-38.3x2.6x
Wed, 27 Nov 2024SEK 41.3bSEK 16.8b-SEK 948,723,426.0047x-43.5x2.5x
Fri, 25 Oct 2024SEK 42.8bSEK 16.7b-SEK 983,175,491.0084.3x-43.5x2.6x
Sun, 22 Sep 2024SEK 47.1bSEK 16.7b-SEK 988,175,491.0057.5x-47.7x2.8x
Tue, 20 Aug 2024SEK 48.6bSEK 16.7b-SEK 1,124,972,538.0062.6x-43.2x2.9x
Thu, 18 Jul 2024SEK 49.7bSEK 16.6b-SEK 1,133,686,510.0061.8x-43.8x3x
Sat, 15 Jun 2024SEK 43.1bSEK 16.3b-SEK 1,188,686,510.0058.1x-36.2x2.6x
Mon, 13 May 2024SEK 40.3bSEK 16.3b-SEK 1,157,635,671.0036.5x-34.8x2.5x
Wed, 10 Apr 2024SEK 39.6bSEK 16.0b-SEK 1,122,792,213.0036x-35.3x2.5x
Fri, 08 Mar 2024SEK 39.0bSEK 16.0b-SEK 1,123,139,210.0039.8x-34.8x2.4x
Sun, 04 Feb 2024SEK 39.0bSEK 15.8b-SEK 1,473,823,683.0055.6x-26.5x2.5x
Tue, 02 Jan 2024SEK 37.7bSEK 15.5b-SEK 1,393,723,683.0045.7x-27x2.4x
Thu, 30 Nov 2023SEK 34.7bSEK 15.4b-SEK 1,395,872,683.0040.9x-24.9x2.2x
Sat, 28 Oct 2023SEK 27.1bSEK 15.3b-SEK 1,256,516,711.0032x-21.6x1.8x
Mon, 25 Sep 2023SEK 27.5bSEK 15.1b-SEK 1,134,516,711.0038.8x-24.2x1.8x
Wed, 23 Aug 2023SEK 29.6bSEK 15.1b-SEK 213,871,038.0041.8x-138.6x2x
Fri, 21 Jul 2023SEK 31.8bSEK 14.9b-SEK 238,476,038.0041.6x-133.3x2.1x
Sun, 18 Jun 2023SEK 40.1bSEK 14.6b-SEK 172,476,038.0038.7x-232.5x2.7x
Price to Earnings Ratio

-232.5x


Total Market Cap: SEK 40.1bTotal Earnings: -SEK 172,476,038.00Total Revenue: SEK 14.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Clinical Research and Equipment Industry Price to Earnings3Y Average 19.2x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 2.4x is higher than the industry's current PS ratio of 2.0x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Swedish Clinical Research and Equipment compare with similar industries?

SE Market-1.86%
Healthcare1.68%
Life Sciences6.68%
Clinical Research and Equipment6.68%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALIF B AddLifeSEK 157.8010.7%
+SEK 1.9b		-19.8%PE33.9x
MCAP MedCapSEK 508.001.2%
+SEK 90.1m		19.8%PE33.9x
GENO Genovis AB (publ.)SEK 20.003.4%
+SEK 43.6m		-24.8%PE54.4x
IDLDX IDL DiagnosticsSEK 0.490.8%
+SEK 921.4k		-9.3%PS2.1x

Latest News

IDLDX
SEK 0.49
IDL Diagnostics
7D
0.8%
1Y
-9.3%
MCAP
SEK 508.00
MedCap
7D
1.2%
1Y
19.8%
MAGLE
SEK 1.18
Magle Chemoswed Holding
7D
-66.1%
1Y
-95.6%
PRO
SEK 10.50
Promimic
7D
-13.2%
1Y
-43.2%
LEVBIO
SEK 0.26
Level Bio
7D
-7.7%
1Y
-39.1%
ALIF B
SEK 157.80
AddLife
7D
10.7%
1Y
-19.8%
BICO
SEK 17.16
BICO Group
7D
-2.1%
1Y
-51.7%
GENO
SEK 20.00
Genovis AB (publ.)
7D
3.4%
1Y
-24.8%
Analysis Article • May 01

Genovis AB (publ.) Just Missed Earnings - But Analysts Have Updated Their Models

Genovis AB (publ.) ( STO:GENO ) shareholders are probably feeling a little disappointed, since its shares fell 4.4% to...
PEXA B
SEK 0.23
PExA
7D
-1.7%
1Y
-40.4%